Making the Grade: The Impact of Low-Grade Toxicities on Patient Preference for Treatment With Novel Agents.
Explore this paper's citation graph
Summary
Anticipation of low-grade toxicities and dosing inconvenience negatively impacts patient willingness to be treated, which may affect adherence and therapeutic outcomes from therapy.
- Type
- article
- Published
- 2015-12-01
- Cited by
- 12
- References
- 24
- Access
- Open access
- OpenAlex
- https://openalex.org/W26656518
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:24161003
Keywords
Focus (optics), Human–computer interaction, Computer science, Product (mathematics), Virtual machine
References
- Agreement between Patient-reported Symptoms and their Documentation in the Medical Record
- Influence of Intention to Adhere, Beliefs and Satisfaction About Medicines on Adherence in Solid Organ Transplant Recipients
- Patient adherence and persistence with oral anticancer treatment
- Adherence and Patients' Attitudes to Oral Anticancer Drugs: A Prospective Series of 201 Patients Focusing on Targeted Therapies
- Treatment of non-small-cell lung cancer with erlotinib or gefitinib.
- The Missing Patient Voice in Drug-Safety Reporting
- Patient adherence to treatment: three decades of research. A comprehensive review
- Treatment-associated adverse event management in the advanced renal cell carcinoma patient treated with targeted therapies.
- Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival.
- Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer.
- Capecitabine non-adherence: Exploration of magnitude, nature and contributing factors
- Unintentional non-adherence to chronic prescription medications: How unintentional is it really?
- Refill adherence to repeat prescriptions of cancer drugs to ambulatory patients.
- Adherence to therapy with oral antineoplastic agents.
- Exploring chronic myeloid leukemia patients' reasons for not adhering to the oral anticancer drug imatinib as prescribed.
- How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30.
- Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes.
- Influence of patients’ disease knowledge and beliefs about medicines on medication adherence: findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine
- Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib.
- Adherence and patients’ experiences with the use of oral anticancer agents
Cited by
- Quality of life of cancer patients on the wave of immunotherapy
- Value-Based Calculators in Cancer: Current State and Challenges.
- Do current approaches to assessing therapy related adverse events align with the needs of long-term cancer patients and survivors?
- The predictive value of cumulative toxicity for quality of life in patients with metastatic colorectal cancer during first-line palliative chemotherapy
- Toxicity-induced modification of treatment: what is in a name?
- Age and the Risk of Paclitaxel‐Induced Neuropathy in Women with Early‐Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101
- Long-Term Quality of Life of Retroperitoneal Sarcoma Patients Treated with Pre-Operative Radiotherapy and Surgery
- When will I feel normal again? Trajectories and predictors of persistent symptoms and poor wellbeing after primary chemotherapy for ovarian cancer.
- What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient Preferences
- Role of solute carrier transporters in the biodistribution and toxicity of chemotherapeutic drugs
- Safety‐Driven Response Adaptive Randomization: An Application in Noninferiority Oncology Trials
- Hybrid design tools for conceptual design and design engineering processes : bridging the design gap : towards an intuitive design tool
- Public Participation in Access to Medicines
Related papers
- LEARNING IN VIRTUAL 3D ENVIRONMENTS: ALL ABOUT IMMERSIVE 3D INTERFACES
- Design issues and experiences from having lessons in text-based social virtual reality environments
- A Phenomenological Framework of Architectural Paradigms for the User-Centered Design of Virtual Environments
- Informing the design of a virtual environment to support learning in children
- Multi-perspective collaborative design in persistent networked virtual environments
- DESIGNING MODELING AND SIMULATION USER EXPERIENCES: AN EMPIRICAL STUDY USING VIRTUAL ART CREATION
- Information-rich virtual environments: theory, tools, and research agenda
- Virtual reality as an empirical research tool - Exploring user experience in a real building and a corresponding virtual model